Prospective randomized trial of azathioprine in cryopreserved valved allografts in children.

[1]  M. Lachat,et al.  Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  M. Yacoub,et al.  Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance. , 1998, The Annals of thoracic surgery.

[3]  A. Bogers,et al.  Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. , 1998, The Annals of thoracic surgery.

[4]  C. Tarsitani,et al.  Simultaneous HLA Class I and Class II antibodies screening with flow cytometry. , 1998, Human immunology.

[5]  D. Ross,et al.  Aortic valve grafts in the rat: evidence for rejection. , 1997, The Journal of thoracic and cardiovascular surgery.

[6]  B. Hepkema,et al.  HLA antibodies specific for cryopreserved heart valve "homografts" in children. , 1997, The Journal of thoracic and cardiovascular surgery.

[7]  L. Lambert,et al.  Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. , 1996, Circulation.

[8]  R. D. de Kleine,et al.  Experimental arterial allografting under low and therapeutic dosages of cyclosporine for immunosuppression. , 1996, Transplantation.

[9]  R. Guidoin,et al.  Fresh venous allografts in peripheral arterial reconstruction in dogs. Effects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil. , 1995, The Journal of thoracic and cardiovascular surgery.

[10]  F J Schoen,et al.  Structure-function correlations in cryopreserved allograft cardiac valves. , 1995, The Annals of thoracic surgery.

[11]  A. C. Yankah,et al.  Accelerated degeneration of allografts in the first two years of life. , 1995, The Annals of thoracic surgery.

[12]  A. C. Yankah,et al.  Short-course cyclosporin A therapy for definite allograft valve survival immunosuppression in allograft valve operations. , 1995, The Annals of thoracic surgery.

[13]  N. Motomura,et al.  Histological change in cryopreserved rat aortic allograft. , 1995, The Journal of cardiovascular surgery.

[14]  Elkins Rc.  Pulmonary autograft: expanding indications and increasing utilizations. , 1994 .

[15]  D. Campbell,et al.  Degeneration of aortic valve allografts in young recipients. , 1993, The Journal of thoracic and cardiovascular surgery.

[16]  L. Lambert,et al.  Effects of homograft blood type and anatomic type on stenosis, regurgitation and calcium in homografts in the pulmonary position. , 1992, The American journal of cardiology.

[17]  G. Sicard,et al.  PRETREATMENT OF RENAL ALLOGRAFT RECIPIENTS WITH IMMUNOSUPPRESSION AND DONOR‐SPECIFIC BLOOD , 1984, Transplantation.

[18]  D. Phelan,et al.  ANTIGENIC SPECIFICITY OF ANTIBODY REACTIVE IN THE ANTIGLOBULIN‐AUGMENTED LYMPHOCYTOTOXICITY TEST , 1982, Transplantation.

[19]  M. Lane,et al.  Cryopreserved homograft valves in the pulmonary position: risk analysis for intermediate-term failure. , 1999, The Journal of thoracic and cardiovascular surgery.

[20]  R. Colvin,et al.  Immunosuppressive treatment of aortic allografts. , 1988, Journal of vascular surgery.